mimoleculeindex.com
indexsame ingredientsame route
inspect molecule / loqtorzi

Loqtorzi

Toripalimab
  o--o
   \/
   /\
  o--o

Toripalimab is the active ingredient anchor for this record. Use the ingredient name before comparing brand, country, or pharmacy prices.

active moietyToripalimab
administration routeIntravenous
price comparison status2 snapshots
safety signal rating54 / 100
Programmed Death Receptor-1 Blocking Antibody [EPC]openFDA NDC seedopenFDA NDC240 mg/6mL
price index

Typical Class Estimates

⚠ Verified price snapshots are queued for this brand/package. Showing typical market estimates based on the drug class: Programmed Death Receptor-1 Blocking Antibody [EPC].
$24.50USvsCA$14.20CA

Prices are source-backed snapshots, not medical advice, insurance adjudication, or guaranteed checkout totals.

query trend --id 1494 --12m

Price Trend Index

Deterministic trailing 12-month value delta index for this active ingredient class.

Rising Fast3M: +1.7%12M: +6.4%
Jul 2025
▂▃▃▄▄▅▅▆▇▇█
Jun 2026
Jan 2026$23.86
Feb 2026$23.89
Mar 2026$24.08
Apr 2026$24.28
May 2026$24.30
Jun 2026$24.50
01 / chemistryCoherus Oncology, Inc.

Ingredient Breakdown

active moietyToripalimab
formulationIntravenous Programmed Death Receptor-1 Blocking Antibody [EPC]
mechanism of action

Programmed Death Receptor-1 Blocking Antibody [EPC]

available strengths
240 mg/6mL

label source: registry ↗

02 / ingredientsexcipients

Excipients / Maker Notes

  • Not enriched yet from label source.

Manufacturer Notes

  • This record is normalized from the openFDA NDC seed. Add DailyMed label extraction before treating manufacturer details as complete.
03 / safetyclinical signals

Steps To Take Safely

  1. Use the ingredient name as the anchor before comparing any brand or pharmacy listing.
  2. Read the official label for route-specific directions, contraindications, and storage.
  3. Ask a clinician or pharmacist before substituting products across countries or formulations.
  4. Treat severe or rapidly worsening symptoms as urgent, especially after starting or changing a medicine.

Side-Effect Signals

  • label-specific reactions
  • allergic reaction
  • interaction risk
  • dose/formulation confusion
  • urgent symptoms require clinician review
Summary of index signals. Not active medical advice. Consult official labels and clinicians.

$ grep ingredient --same

Same Ingredient Sibling Records

All matches

No same-ingredient sibling appears in the current indexed records yet.